L-theanine is a non-proteinogenic amino acid naturally occurring in tea leaves (Camellia sinensis) and responsible for much of tea’s calming-without-sedation profile. It crosses the blood-brain barrier within 30-60 minutes of ingestion, where it modulates GABA-A signaling, promotes alpha-wave activity characteristic of relaxed alertness, and antagonizes glutamate receptors (reducing excitatory neurotransmission). This mechanistic profile distinguishes it from sedative agents: L-theanine does not cause drowsiness at standard doses.
Clinical evidence supports L-theanine for anxiety, sleep quality, and attention enhancement. For acute anxiety, 200-400mg reduces subjective anxiety and cortisol response to stressors within 30-60 minutes. For sleep, 200mg taken 30-60 minutes before bedtime improves subjective sleep quality and sleep onset latency in multiple RCTs. For attention and cognitive performance, the L-theanine plus caffeine combination (200mg theanine with 100mg caffeine, ratio 2:1) has the strongest evidence, with effect sizes SMD 0.3-0.5 in attention tasks while blunting caffeine’s anxiogenic effects.
Safety is excellent across populations. No clinically significant drug interactions are established. L-theanine does not produce tolerance at standard doses and has no withdrawal syndrome. It is appropriate for long-term daily use. Quality considerations favor Suntheanine (a patented enantiomerically pure L-theanine from Taiyo International) over generic products, which may contain D-theanine or lower purity. Pregnancy and lactation safety is insufficiently established for supplemental doses, though dietary exposure from tea consumption is considered safe.